Laura E. Niklason
President, CEO and Director at Humacyte Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Humacyte Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Humacyte Inc. June 11, 202499.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 20, 2025 | Humacyte Inc. | Open-market sale | −591,685 | $1.58 | $934,862 |
| Aug 19, 2025 | Humacyte Inc. | Open-market sale | −1,100,000 | $1.63 | $1,793,000 |
| Aug 18, 2025 | Humacyte Inc. | Open-market sale | −549,360 | $1.83 | $1,005,329 |
| Nov 20, 2024 | Humacyte Inc. | Open-market sale | −261,369 | $4.40 | $1,150,024 |
| Nov 19, 2024 | Humacyte Inc. | Open-market purchase | +1,797 | $4.44 | $7,979 |
| Nov 19, 2024 | Humacyte Inc. | Open-market sale | −427,459 | $4.34 | $1,855,172 |
| Nov 18, 2024 | Humacyte Inc. | Open-market sale | −811,172 | $4.44 | $3,601,604 |
| Sep 10, 2024 | Humacyte Inc. | Open-market sale | −288,674 | $5.23 | $1,509,765 |
| Sep 9, 2024 | Humacyte Inc. | Open-market sale | −157,704 | $5.42 | $854,756 |
| Aug 29, 2024 | Humacyte Inc. | Open-market purchase | +1,222 | $6.55 | $8,004 |
| Aug 29, 2024 | Humacyte Inc. | Open-market sale | −352,112 | $6.35 | $2,235,911 |
| Aug 28, 2024 | Humacyte Inc. | Open-market sale | −277,090 | $6.47 | $1,792,772 |
| Aug 27, 2024 | Humacyte Inc. | Open-market sale | −252,676 | $6.71 | $1,695,456 |
| Jun 12, 2024 | Humacyte Inc. | Open-market sale | −271,518 | $7.30 | $1,982,081 |
| Jun 11, 2024 | Humacyte Inc. | Open-market sale | −282,000 | $7.09 | $1,999,380 |
Questions about Laura E. Niklason
What boards is Laura E. Niklason on?
Laura E. Niklason sits on the board of Humacyte Inc.
What company is Laura E. Niklason the CEO of?
Laura E. Niklason is President, CEO and Director of Humacyte Inc.
How long has Laura E. Niklason served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.